Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2015 | T cells targeting multiple tumor-associated antigens in lymphoma

Catherine Bollard • 4 Dec 2015
ASH 2015
Hodgkin Lymphoma Non-Hodgkin Lymphoma

At the 58th American Society of Hematology (ASH) Annual Meeting & Exposition, Catherine Bollard, MBChB, MD, FRACP, FRCPA, from Children’s National Medical Center, Washington, DC, discusses the development of a protocol for the generation of single T-cell lines that simultaneously target a range of tumor-associated antigens that are frequently expressed in tumours of individuals with Hodgkin lymphoma and non-Hodgkin lymphoma, including PRAME, SSX2, MAGEA4, NY-ESO-1 and Survivin.

More from Catherine Bollard

3:52
The GVL effect of VSTs
Catherine Bollard • 5 Oct 2021
1:23
ASH 2021: key upcoming data
Catherine Bollard • 5 Oct 2021
2:20
CAR-transduced NK cell therapy
Catherine Bollard • 5 Oct 2021
2:02
Advances in off-the-shelf CAR T-cells
Catherine Bollard • 5 Oct 2021

Related Videos

3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
2:28
Checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to alloSCT for HL
Jacopo Mariotti • 15 Apr 2024
1:37
Exciting CAR-T clinical trials in LBCL and FL
Gloria Iacoboni • 15 Apr 2024
1:48
Novel immunotherapy approaches in lymphoma: CAR-T cells, bispecifics & sequencing
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals